|1.||López-Sanromà, Sílvia: 1 article (03/2015)|
|2.||Holvoet, Paul: 1 article (03/2015)|
|3.||Rull, Anna: 1 article (03/2015)|
|4.||Camps, Jordi: 1 article (03/2015)|
|5.||Joven, Jorge: 1 article (03/2015)|
|6.||García-Heredia, Anabel: 1 article (03/2015)|
|7.||Geeraert, Benjamine: 1 article (03/2015)|
|8.||Curry, Leslie L: 1 article (07/2008)|
|9.||Lubin, B C: 1 article (07/2008)|
|10.||Schwartz, S L: 1 article (07/2008)|
|1.||Type 2 Diabetes Mellitus (MODY)
07/01/2008 - "These results suggest that chronic use of 1000mg rebaudioside A does not alter glucose homeostasis or blood pressure in individuals with type 2 diabetes mellitus."
07/01/2008 - "Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus."
07/01/2008 - "This trial evaluated the effects of 16 weeks of consumption of 1000mg rebaudioside A (n=60) a steviol glycoside with potential use as a sweetener, compared to placebo (n=62) in men and women (33-75 years of age) with type 2 diabetes mellitus. "
10/01/2004 - "The effect of rebaudioside A is critically dependent on the presence of extracellular Ca2+, ie, rebaudioside A-induced insulin stimulation at high glucose disappears in the absence of extracellular Ca2+. In conclusion, rebaudioside A possesses insulinotropic effects and may serve a potential role as treatment in type 2 diabetes mellitus."
|2.||Body Weight (Weight, Body)
07/01/2008 - "The survival and general condition of the F1 and F2 offspring, their pre-weaning reflex development, overall body weight gains, and the timing of sexual maturation, were not adversely affected by rebaudioside A treatment. "
07/01/2008 - "Rebaudioside A treatment was not associated with any signs of clinical toxicity or adverse effects on body weight, body weight gain, or food consumption. "
07/01/2008 - "Using this method, the estimated dietary exposures for rebaudioside A in average and high consumers are predicted to be 1.3 and 3.4mg/kg body weight per day for the general population, 2.1 and 5.0mg/kg body weight per day for children and 3.4 and 4.5mg/kg body weight per day for children with diabetes. "
07/01/2008 - "34-39] was set at 0-2mg/kg body weight (expressed as steviol equivalents); after correction for the difference in molecular weights, these estimated intakes of rebaudioside A are equivalent to daily steviol intakes of less than 2mg/kg. In consequence, this analysis shows that the intakes of rebaudioside A would not exceed the JECFA temporary ADI set for steviol glycosides."
|2.||Sweetening Agents (Sweeteners)